Aug-11-22 04:30AM
Quoin Pharmaceuticals to Report Second Quarter 2022 Financial Results and Provide Corporate Update on August 18th GlobeNewswire Inc.
Aug-09-22 04:23AM
Quoin Pharmaceuticals Announces Closing of $16.8 Million Public Offering GlobeNewswire Inc.
03:24AM
Why Karuna Therapeutics Jumped Around 72%; Here Are 96 Biggest Movers From Yesterday Benzinga
Aug-08-22 12:49PM
Why CinCor Pharma Is Trading Higher By 63%, Here Are 79 Stocks Moving In Monday's Mid-Day Session Benzinga
06:08AM
Why Is NuZee Down By Over 21%: Here Are 38 Stocks Moving Premarket Benzinga
Aug-08-22 03:05AM
Why Quoin Pharmaceuticals Plunged Over 62%; Here Are 120 Biggest Movers From Friday Benzinga
Aug-05-22 03:06AM
Nasdaq Falls Over 100 Points, Marker Therapeutics Shares Spike Higher Benzinga
12:53PM
Why Cooper-Standard Is Trading Higher By 70%, Here Are 81 Stocks Moving In Friday's Mid-Day Session Benzinga
Aug-05-22 12:02PM
Dow Drops 150 Points, Crude Oil Rises Over 2% Benzinga
10:08AM
Markets Open Lower; U.S. Economy Adds Higher-Than-Expected Jobs In July Benzinga
Aug-05-22 09:28AM
Quoin Pharmaceuticals Announces Pricing of $16.8 Million Upsized Public Offering GlobeNewswire Inc.
07:35AM
Why Is Marker Therapeutics Trading Higher By 119%: Here Are 42 Stocks Moving Premarket Benzinga
Aug-05-22 06:12AM
Why NanoViricides Jumped Over 48%; Here Are 106 Biggest Movers From Yesterday Benzinga
Aug-04-22 01:12AM
Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday's Mid-Day Session Benzinga
06:51AM
Why Is Yellow Trading Higher By 33%: Here Are 48 Stocks Moving Premarket Benzinga
Aug-04-22 05:54AM
This Biotechnology Stock Jumped Over 360%; Here Are 106 Biggest Movers From Yesterday Benzinga
Jun-06-22 09:47AM
Penny Stocks To Buy Now? 4 To Watch With Big News PennyStocks
May-06-22 10:02AM
Benzinga's Top Ratings Upgrades, Downgrades For May 6, 2022 Benzinga
Apr-25-22 10:37AM
4 Hot Penny Stocks To Buy For Under $5 Outperforming Dogecoin In April PennyStocks
Mar-15-22 08:41AM
Quoin Pharmaceuticals Announces Submission of IND for its Lead Asset, QRX003, for Netherton Syndrome GlobeNewswire Inc.
Mar-10-22 08:00AM
Quoin Pharmaceuticals Submits Scientific Advice Briefing Document to EMA for its Lead Asset, QRX003, for Netherton Syndrome GlobeNewswire Inc.
Mar-01-22 08:00AM
Quoin Pharmaceuticals Extends Exclusive Distribution Agreement with ER-Kim for its Lead Asset, QRX003, for Netherton Syndrome GlobeNewswire Inc.
Quoin Pharmaceuticals Ltd (QNRX) Stock Discussions on Social Media
Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. It offers QRX003, a potential therapy for the treatment of Netherton Syndrome; QRX004, a topical lotion for the treatment recessive dystrophic epidermolysis bullosa; and QRX006, a topical lotion to treat rare skin disease. The company was founded in 2018 and is based in Ashburn, Virginia.
We use cookies for analytics and to improve our site. Learn More
Accept